A recently published study evaluated incident cardiovascular disease (CVD) and the initiation as well as subsequent adherence to statin treatment for the treatment of primary prevention in those who...
This review of the literature published in the Journal of Vascular Health and Risk Management (Reynolds et al, 2021), looked at the important area of the use of the drug group statins and the...
Recent accumulating evidence on the use of newer therapies in type 2 diabetes (T2DM) is helping to define their position in treatment. This information coupled with the increasing priority given...
According to statistics from the British Heart Foundation (BHF) there are 830 000 women in the UK living with coronary heart disease (CHD), and around 380 000 women in the UK have survived a heart...
Cardiac electrical impulses originate high in the hearts upper right chamber, the right atrium, at a highly dense area of electrical tissue called the sinoatrial (SA) node, located just below the...
The drug doxorubicin slows or stops the spread of cancer cells by blocking the enzyme, topoisomerase, which cancer cells rely on for their division and growth (Cancer Research UK (CRUK), 2019). It is...
The action of SGLT2 inhibitors is to reduce renal glucose and sodium reabsorption in the proximal tubule of the nephron resulting in increased urinary glucose excretion with osmotic and natriuretic...
Alongside important lifestyle changes, first-line treatment for heart failure is an angiotensin-converting enzyme (ACE) inhibitor and a beta blocker licensed for heart failure in people with reduced...
‘Fake medical news and fearmongering… plague the cardiovascular world through relentless attacks on statins’ .
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills